CommentImproving observational studies in the era of big data
References (7)
- et al.
Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations
J Clin Epidemiol
(2015) Seven myths of randomisation in clinical trials
Stat Med
(2013)- et al.
Routine imaging for diffuse large B-cell lymphoma in first complete remission does not improve post-treatment survival: a Danish–Swedish population-based study
J Clin Oncol
(2015)
There are more references available in the full text version of this article.
Cited by (26)
Developing an ETL tool for converting the PCORnet CDM into the OMOP CDM to facilitate the COVID-19 data integration
2022, Journal of Biomedical InformaticsCitation Excerpt :Widespread enthusiasm for big data approaches has led to increasing popularity in conducting large observational studies in the assessment of new medical technologies in recent years [1].
Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data
2021, Clinical Breast CancerCitation Excerpt :Similarly, the integration of omics data with RWD requires a controlled approach for large-scale data analytics.24 RWE and integrated omics data have the power to impact patient care.3,25-27 Various studies show the additive value of molecular tumor profiling with RWD for clinically relevant breast cancer insights,8,28 but further advancements in the field require the integration of genetic and clinical data from a variety of institutions, along with omics-focused capabilities and data analytics.
Big data and precision oncology in healthcare
2023, Big Data in Oncology: Impact, Challenges, and Risk Assessment
© 2018 Elsevier Ltd. All rights reserved.